Company intelligence / Profile preview
Stragen
Geneva / Plan-les-Ouates, Switzerlandstragen.com ↗
- Ownership
- Private
- Employees
- ~163
- Development stage
- Other
01
Overview
Stragen specializes in the development and commercialization of hard-to-make generic medicines and niche hospital pharmaceuticals with a focus on life-threatening conditions requiring intensive care. The company operates globally across more than sixty countries with a strong presence in Europe. Its portfolio covers oncology, cardiology, neurology, anti-infectives/antifungals as well as women’s health. In addition to generics and consumer health products—including natural formulations—Stragen invests in the development of patented new drugs addressing orphan diseases or unmet medical needs.
- Therapeutic areas
- CardiovascularEndocrinologyImmunologyWomen's HealthOncologyNeurologyInfectious Diseases
- Modalities
- Small molecules (generics and niche hospital medicines)Parenteral drugs (e.g., antibiotics including penicillin)Cytostatic agents (oncology drugs)Hormonal productsTopical productsNatural formulations for consumer health
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Works with an extensive network of partners for global distribution but no specific major pharma partnerships named.
Beyond the preview
Go deeper on Stragen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stragen.